Uni Agencies Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.92 M
as on 17-07-2024
- Company Age 40 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.75 Cr
as on 17-07-2024
- Revenue -24.51%
(FY 2023)
- Profit -60.14%
(FY 2023)
- Ebitda 16.13%
(FY 2023)
- Net Worth 0.34%
(FY 2023)
- Total Assets 4.66%
(FY 2023)
About Uni Agencies Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.92 M.
The company currently has active open charges totaling ₹44.75 Cr.
Harshad Vaid and Dheeraj Sharma serve as directors at the Company.
- CIN/LLPIN
U74899DL1984PTC018166
- Company No.
018166
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Uni Agencies Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshad Vaid  | Managing Director | 21-May-1984 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dheeraj Sharma | Director | 05-Jun-2019 | Current |
Financial Performance of Uni Agencies Chemicals.
Uni Agencies Chemicals Private Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.51% decrease. The company also saw a substantial fall in profitability, with a 60.14% decrease in profit. The company's net worth moved up by a moderate rise of 0.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uni Agencies Chemicals?
In 2023, Uni Agencies Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 27 Mar 2018 | ₹14.90 Cr | Open |
Syndicate Bank Creation Date: 24 Mar 2015 | ₹2.00 Cr | Open |
Syndicate Bank Creation Date: 28 Dec 2009 | ₹1.00 Cr | Open |
How Many Employees Work at Uni Agencies Chemicals?
Uni Agencies Chemicals has a workforce of 2 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uni Agencies Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uni Agencies Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
